TBA (last known deadline was August 1, 2012)
The GLRCE Developmental Projects Program will support innovative research that will contribute to the development of new vaccines, therapeutics and/or adjuvants against biological agents from the NIAID Category A, B & C Priority Pathogens and EID while advancing basic knowledge on the mechanisms of disease and/or immunity to disease.